These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32499580)

  • 21. Today's dilemma--will drugs work?
    Dowling HF
    J Am Pharm Assoc; 1971 Jun; 11(6):331-3. PubMed ID: 5118797
    [No Abstract]   [Full Text] [Related]  

  • 22. Product dissolution methods.
    Leeson LJ
    J Pharm Sci; 1973 Apr; 62(4):IV. PubMed ID: 4699003
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug product quality.
    J Am Pharm Assoc; 1970 Feb; 10(2):107-16. PubMed ID: 5411068
    [No Abstract]   [Full Text] [Related]  

  • 24. Editorial: Bioavailability, bioequivalence and bias.
    Leopold IH
    Am J Ophthalmol; 1975 Mar; 79(3):518. PubMed ID: 1122003
    [No Abstract]   [Full Text] [Related]  

  • 25. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biopharmaceuticals from microorganisms: from production to purification.
    Jozala AF; Geraldes DC; Tundisi LL; Feitosa VA; Breyer CA; Cardoso SL; Mazzola PG; Oliveira-Nascimento L; Rangel-Yagui CO; Magalhães PO; Oliveira MA; Pessoa A
    Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):51-63. PubMed ID: 27838289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant drug development, regulation, and commercialization: an Indian industry perspective.
    Sahoo N; Manchikanti P
    BioDrugs; 2011 Apr; 25(2):105-13. PubMed ID: 21230010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional intestinal drug permeation: biopharmaceutics and drug development.
    Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biopharmaceutical features. II. Appendices].
    Gallo U
    Boll Chim Farm; 1970 Feb; 109(2):81-90. PubMed ID: 5454981
    [No Abstract]   [Full Text] [Related]  

  • 30. Prescription drugs and the patient's health.
    Woods D
    Can Med Assoc J; 1974 Dec; 111(11):1269 passim. PubMed ID: 4154804
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of specifications for biotechnology products--perspective from Europe.
    Trouvin JH
    Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacokinetics and its practical developments in biopharmaceutical studies. I].
    Bieder A; Gaillot J
    Ann Pharm Fr; 1971 Nov; 29(11):553-68. PubMed ID: 5138618
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global perspective on specifications for biotechnology products--perspective from Japan.
    Hayakawa T
    Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
    [No Abstract]   [Full Text] [Related]  

  • 35. General principles in the characterization and use of model systems for biopharmaceutical studies.
    Borchardt RT; Smith PL; Wilson G
    Pharm Biotechnol; 1996; 8():1-11. PubMed ID: 8791801
    [No Abstract]   [Full Text] [Related]  

  • 36. [The role of biopharmaceutical parameters in drug development (author's transl)].
    Thoma K
    Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability: a practitioner's point of view.
    Fedder DO
    J Am Pharm Assoc; 1974 Aug; 14(8):404-6. PubMed ID: 4850769
    [No Abstract]   [Full Text] [Related]  

  • 38. Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system (BDDCS).
    Li J; Larregieu CA; Benet LZ
    Chin J Nat Med; 2016 Dec; 14(12):888-897. PubMed ID: 28262115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologic availability and therapeutic equivalence.
    Arnold JD; Sicé J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):546-9. PubMed ID: 977793
    [No Abstract]   [Full Text] [Related]  

  • 40. Advances in biopharmaceutical analysis in the People's Republic of China 1995-1997.
    Qin Z
    J Pharm Biomed Anal; 1998 Jun; 17(2):183-92. PubMed ID: 9638571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.